GBS Inc: Slumps in Nasdaq debut
** Shares of GBS Inc GBS.O slump 45.6% to $9.24 in Nasdaq
debut
** Co's IPO was priced at $17 per share urn:newsml:reuters.com:*:nGNX13b70n
** GBS offered 1.27 mln shares in IPO, raising ~$21.6 mln
** Dawson James Securities Inc was sole book-running manager
for GBS's listing
(Reporting by Sohini Podder in Bengaluru)
((sohini.podder@thomsonreuters.com))
Recent news on Intelligent Bio Solutions
See all newsBrief: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth Of 38% Year-Over-Year, Driven By Reader Installed Base And High-Margin Cartridge Growth
Brief: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50%
Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing
Brief: Intelligent Bio Solutions Completes Clinical Cut-Off Study